Oral Abstract Session:
123. Stewardship Tools
Friday, October 6, 2017: 8:30 AM-10:00 AM
Room: 05AB

Moderators:  Rebekah W. Moehring, MD, MPH, Duke University Medical Center and Pranita Tamma, MD, MHS, Johns Hopkins University School of Medicine

8:30 AM
Getting it Right the First Time: Relating Pharmacokinetic-Pharmacodynamic Target Attainment and Patient Outcomes
Catharine C. Bulik, Pharm.D.; Justin C. Bader, Pharm.D., MBA; Elizabeth A. Lakota, Pharm.D., M.S.; Sujata M. Bhavnani, Pharm.D., M.S.; Christopher M. Rubino, Pharm.D.; Kim L. Sweeney, Pharm.D.; Paul G. Ambrose, Pharm.D., FIDSA; Robert C. Owens Jr., Pharm.D.
8:45 AM
Pharmacodynamic Target Attainment for Meropenem and Piperacillin/Tazobactam Using a PK/PD-based Dosing Calculator in Critically Ill Patients
Emily Heil, PharmD, BCPS-AQID; David P. Nicolau, PharmD, FCCP, FIDSA; Gwen Robinson, MPH; Andras Farkas, PharmD; Kerri Thom, MD, MS
9:00 AM
A Novel Antimicrobial Stewardship Program-Guided Procalcitonin Initiative for Emergency Department Diagnosis of Bacterial Pneumonia in New York City
George D. Rodriguez, Pharm.D.; Roman Yashayev, P.A.-C.; Bella Yushuvayev, P.A.-C.; Anna Kula, P.A.-C.; Nathan Warren, P.A.-C.; Geeti Dhillon, M.D.; Demetra Tsapepas, PharmD, BCPS; Caroline Keane, RN, MSN, ANP; William H. Rodgers, M.D., Ph.D.; Jonathan Siegal, M.D.; Manish Sharma, D.O., MBA; Sorana Segal-Maurer, M.D.
9:15 AM
Communicating Microbiology Results: It’s Not Just What You Say, But How You Say It.
Mary Musgrove, PharmD; Rachel M Kenney, PharmD; Ronald Kendall, PharmD; Robert Tibbetts, Ph.D. D(ABMM), F(CCM); Linoj Samuel, PhD., D(ABMM); Mike Peters, PharmD, BCPS; Susan Davis, PharmD
9:30 AM
Can antibiotic de-escalation be measured without chart review? A proposed electronic definition
Rebekah W. Moehring, MD, MPH; Xinru Ren, MS; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; Angelina Davis, PharmD, MS; April Dyer, PharmD, MBA, MSCR, BCPS; Yuliya Lokhnygina, MS, PhD; Lauri Hicks, DO; Arjun Srinivasan, MD, FSHEA; Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS
9:45 AM
The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy
Darunee Chotiprasitsakul, MD, MPH; Pranita Tamma, MD, MHS; Avinash Gadala, MS, B.Pharma; Sara E. Cosgrove, MD, MS

CME Credits: No CME credit is offered for this session.

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.